• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Farxiga and Bydureon are Dead!

anonymous

Guest
Jardiance is killing Farxiga, while Trulicity and Victoza are burying Bydureon. Auto-injector to launch in Q1 2018, but so will Novo's once-weekly which proved to be superior to Trulicity. How now, brown cow?
 
















Similar threads